Clinical Centre of Excellence for Personality Disorders in Older Adults, Mondriaan Mental Health Center, Heerlen-Maastricht, The Netherlands.
Department Psychology (PE), Personality and Psychopathology Research group (PEPS), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Clin Gerontol. 2023 Jul-Sep;46(4):532-543. doi: 10.1080/07317115.2022.2102457. Epub 2022 Jul 21.
Measurements are often developed for the assessment of personality disorders (PDs) in younger adults and seldom evaluated on the applicability in older adults. Remarkably, research has not yet been conducted into age-group appropriateness of the gold standard for the assessment of PDs, known as Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). Therefore, the current study empirically investigated the age-neutrality of the PDs assessed by the SCID-II.
Age-neutrality was examined in 84 younger adults (aged 20-45 years) and 68 older adults (aged 65-85) by Differential Item Functioning (DIF). The impact of DIF on scale level was further examined using Differential Test Functioning analyzes to examine the impact of the amount of DIF variance in the items on scale level.
Overall, the great majority, 95.8% of the categorically measured items and 87.5% of the dimensionally measured items, was endorsed in the same way by younger adults and older adults with equal scores on the PD scale. Subsequent analyzes revealed no large DTF for PD scales.
Overall the SCID-II in an outpatient population is age-neutral for both categorically and dimensionally scored PD scales.
The SCID-II can be used for the assessment of PDs in older adults.
人格障碍(PD)的评估通常是针对年轻成年人进行的,很少评估其在老年成年人中的适用性。值得注意的是,尚未针对 PD 评估的金标准,即 DSM-IV 人格障碍的结构临床访谈(SCID-II),进行年龄分组适用性的研究。因此,目前的研究通过实证研究来检验 SCID-II 评估的 PD 是否具有年龄中立性。
通过差异项目功能(DIF),在 84 名年轻成年人(20-45 岁)和 68 名老年成年人(65-85 岁)中检验年龄中立性。使用差异测试功能分析进一步检验 DIF 对量表水平的影响,以检验项目中的 DIF 方差量对量表水平的影响。
总体而言,绝大多数,95.8%的分类测量项目和 87.5%的维度测量项目,在具有相同 PD 量表得分的年轻成年人和老年成年人中以相同的方式得到认可。随后的分析显示,PD 量表没有大的 DTF。
总体而言,在门诊人群中,SCID-II 对于分类和维度评分的 PD 量表都是年龄中立的。
SCID-II 可用于老年成年人的 PD 评估。